Fig. 2From: Medulloblastoma: clinicopathological parameters, risk stratification, and survival analysis of immunohistochemically validated molecular subgroupsKaplan-Meier curves for overall survival (OS) and progression-free survival (PFS) in medulloblastoma patientsBack to article page